SALUS, Ljubljana, d. d. (LJSE:SALR)

Slovenia flag Slovenia · Delayed Price · Currency is EUR
62.00
+1.00 (1.64%)
At close: Feb 25, 2026
Market Cap509.59M +137.1%
Revenue (ttm)673.54M +4.9%
Net Income14.48M +11.1%
EPS1.76 +10.5%
Shares Out8.22M
PE Ratio35.26
Forward PEn/a
Dividend1.20 (1.94%)
Ex-Dividend DateJan 15, 2026
Volume154
Average Volume1,710
Open61.00
Previous Close61.00
Day's Range61.00 - 62.00
52-Week Range27.18 - 62.00
Beta0.48
RSI74.82
Earnings DateFeb 27, 2026

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1969
Employees 618
Stock Exchange Ljubljana Stock Exchange
Ticker Symbol SALR
Full Company Profile

Financial Performance

In 2024, SALUS, Ljubljana, d. d.'s revenue was 648.83 million, an increase of 8.24% compared to the previous year's 599.44 million. Earnings were 12.85 million, an increase of 25.14%.

Financial Statements